Samir B Amin, MBBS, Ph.D.

Postdoctoral Associate

Working in the comparative oncology field to study spontaneous development of glioma in Canis familiaris or dogs with emphasis on characterizing and comparing cancer genome and transcriptome to that in human glioma.

Visit The Verhaak Lab

Contact me at: 860-837-2022

Connect with me:

About Samir B Amin, MBBS, Ph.D.

Dr. Amin received his Ph.D. in cancer computational biology from Baylor College of Medicine, Houston, TX in 01/2017. His thesis work was carried out at the UT MD Anderson Cancer Center, and was focused on understanding long non-coding RNA interactions in the context of chromatin organization using integrated analyses of publically available expression, epigenomic and chromatin interaction data. Before completing Ph.D., Dr. Amin received research training (2008-2011) in computational biology at the Dana-Farber Cancer Institute, Boston, MA where he worked on the assessment of gene expression profiling as predictive biomarker in multiple myeloma. Previously, Dr. Amin received his first professional degree in medicine, MBBS from the Medical College of Maharaja Sayajirao University of Baroda, Vadodara, India in 2005.

Download CV

Education and experience

Education:

Bachelor of Medicine, Bachelor of Surgery (MBBS) 11/1998-03/2005 Maharaja Sayajirao University of Baroda, Vadodara, Gujarat India
Ph.D. 08/2011-01/2017 Cancer Computational Biology, Graduate Program in Structural and Computational Biology & Molecular Biophysics (SCBMB), Baylor College of Medicine, Houston, TX

Experience:

Postdoctoral fellow 2017-Present Verhaak Lab at the Jackson Laboratory for Genomic Medicine, Farmington, CT
Graduate Student 2011-2016 Baylor College of Medicine and the UT MD Anderson Cancer Center, Houston, TX
Research fellow 2008-2011 Dana-Farber Cancer Institute, Boston, MA
Resident physician 2006-2007 Bhailal Amin General Hospital, Vadodara, GJ, India

Honors and accomplishments

Prof. John J. Trentin Award for Scholastic Excellence
2012 Baylor College of Medicine, Houston, TX

Selected Publications

View full list of publications

Research HighlightJune 21, 2018
Finding the genes controlling ovarian reserve could hold key to better female fertility care
Jackson Laboratory Assistant Professor Ewelina Bolcun-Filas, Ph.D., is looking at how multiple genetic factors regulating oocyte development determine the differences in each woman’s ovarian reserve.
Tech CornerMay 04, 2018
What's new in cancer research?
The field of cancer immunotherapy research is extremely exciting, yet still somewhat mysterious, as researchers grapple with the fine-tuning of patient response.
- Cancer/Tumors
- Cancer
Search MagazineApril 27, 2018
Finding precise cures for cancer
At JAX's new speaker event series, JAXtaposition, two scientific leaders shared how the Maine Cancer Genomics Initiative and JAX’s cutting-edge genomic testing is giving physicians access to the most advanced precision cancer care for their patients.
- Cancer/Tumors
- Cancer
Research HighlightApril 10, 2018
Cancer research: Beyond the Petri dish
The latest developments in cancer research and their translation to oncology practice offer truly exciting potential for better therapies in the near future.

Research HighlightJune 11, 2018
Measuring tumor heterogeneity for better, evolution-based cancer treatment strategies
JAX Associate Professor Jeffrey Chuang, Ph.D., has been awarded a five-year grant totaling $2,650,484 from the National Cancer Institute for research that could pave the way for the first evolution-based approaches to cancer treatment.
- Cancer/Tumors
- Cancer
Press ReleaseApril 30, 2018
Detecting human genome structural variation with long read sequencing
A research team led by Chia-lin Wei is using technology to more easily detect and classify important types of difficult-to-find genomic alterations, known as structural variants.
- Genetic Tools
- Genetics and Genomics
Press ReleaseApril 23, 2018
The role of extra DNA in cancer evolution and therapy resistance
New research is providing a better understanding of the processes underlying cell-to-cell differences within glioblastoma tumors — a crucial finding because these differences contribute to therapy resistance.
- Cancer/Tumors
- Cancer
Tech CornerApril 10, 2018
Cancer and its immune environment bioprinted and reproduced live and in 3D
New 3D bioprinting technique creates a platform for precision immunotherapy study.